Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $189.42 | 8 | 92.0% |
| Education | $16.58 | 2 | 8.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $129.27 | 3 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $62.84 | 6 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.89 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $129.27 | 3 | GlaxoSmithKline, LLC. ($129.27) |
| 2017 | $76.73 | 7 | Sunovion Pharmaceuticals Inc. ($62.84) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), BREO, INCRUSE | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: RESPIRATORY | ||||||
| 05/22/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $102.15 | General |
| Category: RESPIRATORY | ||||||
| 10/19/2017 | Sunovion Pharmaceuticals Inc. | SEEBRI (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: RESPIRATORY | ||||||
| 04/25/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: RESPIRATORY | ||||||
| 04/19/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 04/12/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: RESPIRATORY | ||||||
| 03/29/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: RESPIRATORY | ||||||
| 02/23/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: RESPIRATORY | ||||||
| 02/02/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: RESPIRATORY | ||||||
About Dr. Anne Hebert, MD
Dr. Anne Hebert, MD is a Pulmonary Disease healthcare provider based in Narragansett, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1144227018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anne Hebert, MD has received a total of $206.00 in payments from pharmaceutical and medical device companies, with $129.27 received in 2018. These payments were reported across 10 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($189.42).
Practice Information
- Specialty Pulmonary Disease
- Location Narragansett, RI
- Active Since 07/07/2005
- Last Updated 07/08/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1144227018
Products in Payments
- NUCALA (Biological) $102.15
- UTIBRON (Drug) $23.79
- BROVANA (Drug) $19.99
- SEEBRI (Drug) $19.06
- ANORO (Drug) $19.02
- STIOLTO (Drug) $13.89
- TRELEGY ELLIPTA (Drug) $8.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.